|
|
|
|
|
by robbiep
4933 days ago
|
|
This appears to build on similar work using modified T-cells against Chronic Lymphocytic Leukemia from back in 2005 [1] Fascinating stuff and it seems like all of the leukemias may fall to a strategy like this one. One of the advantages of the use of this treatment in CLL was that patients were 'immunised' against recurrence of the cancer in the future. It seems that it is not yet known if this is the case for the treatment discussed here. Nice to see that work is progressing by leaps and bounds in this area. [1] http://www.nejm.org/doi/full/10.1056/NEJMoa1103849 |
|